Fer pour Perte Capillaire par Carence en Fer

References

1. [1] A Culebras. Rev Neurol. [Restless leg syndrome. Diagnosis and treatment]. PubMed
2. [2] Reyhan Yuksek et al.. Neurol India. 2026. Restless Leg Syndrome and Association with Serum NT Pro-CNP. doi:10.4103/neuroindia.NI_673_19 PubMed
3. [3] Ömer Karakoyun et al.. J Cosmet Dermatol. 2025. Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. doi:10.1111/jocd.70037 PubMed
4. [4] Thomas Dye et al.. Sleep Med Clin. 2025. Iron Metabolism and the Role of Iron Therapy in Pediatric Restless Leg Syndrome. doi:10.1016/j.jsmc.2025.02.005 PubMed
5. [5] Nishantan Thamotharan et al.. Cureus. 2025. Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium. doi:10.7759/cureus.100249 PubMed
6. [6] Umer Younas et al.. J Pak Med Assoc. 2025. Optimizing Restless Legs Syndrome Care: Integrating Rehabilitation into Multimodal Management. doi:10.47391/JPMA.25-97 PubMed
7. [7] Parimala Elangovan et al.. Cureus. 2025. Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic Kidney Disease: A Cross-Sectional Observational … doi:10.7759/cureus.86188 PubMed
8. [8] Namrata Chhabra et al.. Int J Trichology. 2025. Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases. doi:10.4103/ijt.ijt_38_22 PubMed
9. [9] Amy M Phillips et al.. South Med J. 2025. Restless Leg Syndrome and Pregnancy. doi:10.14423/SMJ.0000000000001823 PubMed
10. [10] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
11. [11] Osman S Ipsiroglu et al.. Nutrients. 2024. Iron Deficiency and Restless Sleep/Wake Behaviors in Neurodevelopmental Disorders and Mental Health Conditions. doi:10.3390/nu16183064 PubMed
12. [12] Nermeen Ibrahim Bedair et al.. Arch Dermatol Res. 2024. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case … doi:10.1007/s00403-024-03004-1 PubMed
13. [13] Boutros Soutou et al.. Indian J Dermatol. 2024. Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study. doi:10.4103/ijd.ijd_744_22 PubMed
14. [14] Apostolos Manolopoulos et al.. Ann Neurol. 2024. Brain Iron Dysregulation in Iron Deficiency Anemia-Related Restless Leg Syndrome Revealed by Neuron-Derived Extracellular Vesicles: A Case-Control Study. doi:10.1002/ana.26941 PubMed
15. [15] J Karregat et al.. Transfusion. 2024. Iron deficiency-related symptoms in non-anemic whole blood donors. doi:10.1111/trf.17983 PubMed
16. [16] Syeda Nimra Qadri et al.. Sleep Med. 2024. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients. doi:10.1016/j.sleep.2024.09.017 PubMed
17. [17] Leyla Bilik et al.. North Clin Istanb. 2024. Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin … doi:10.14744/nci.2023.33269 PubMed
18. [18] Sarah Hughes et al.. Healthcare (Basel). 2024. Intersecting Pathways: Treating Cocaine Withdrawal and Restless Leg Syndrome with Iron and Buproprion. doi:10.3390/healthcare12161570 PubMed
19. [19] Yasaman Safarpour et al.. Tremor Other Hyperkinet Mov (N Y). 2023. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review. doi:10.5334/tohm.752 PubMed
20. [20] Sherifa Ahmed Hamed et al.. Int J Neurosci. 2023. Restless leg syndrome in patients with chronic kidney disease: a hospital-based study from Upper Egypt. doi:10.1080/00207454.2021.1910256 PubMed
21. [21] Vivien Chen et al.. Pediatr Dermatol. 2023. Etiology, management, and outcomes of pediatric telogen effluvium: A single-center study in the United States. doi:10.1111/pde.15154 PubMed
22. [22] Jacob L Edelson et al.. Sleep. 2023. The genetic etiology of periodic limb movement in sleep. doi:10.1093/sleep/zsac121 PubMed
23. [23] Swapna N Deshpande et al.. Child Adolesc Psychiatr Clin N Am. 2023. Complementary and Integrative Approaches to Sleep Disorders in Children. doi:10.1016/j.chc.2022.08.008 PubMed
24. [24] Hakan Arslan et al.. Dermatol Pract Concept. 2023. Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. doi:10.5826/dpc.1303a202 PubMed
25. [25] Ashley E Benson et al.. Eur J Haematol. 2022. The incidence, complications, and treatment of iron deficiency in pregnancy. doi:10.1111/ejh.13870 PubMed
26. [26] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
27. [27] Zhao Liu et al.. Medicine (Baltimore). 2022. Exploration of restless legs syndrome under the new concept: A review. doi:10.1097/MD.0000000000032324 PubMed
28. [28] Rosalia Silvestri et al.. Front Psychiatry. 2022. Behavioral sleep medicine-The need for harmonization of clinical best practice outcome measures in children and adolescents with intellectual or developmental … doi:10.3389/fpsyt.2022.1003019 PubMed
29. [29] Ümran Öner et al.. Turk J Med Sci. 2022. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? doi:10.3906/sag-2106-28 PubMed
30. [30] Saadet İbiş et al.. Dermatol Pract Concept. 2022. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. doi:10.5826/dpc.1203a151 PubMed
31. [31] Sandra Iskandar et al.. Case Rep Crit Care. 2022. Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review. doi:10.1155/2022/2447461 PubMed
32. [32] Muhammad Fawad Aslam et al.. Cureus. 2022. The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. doi:10.7759/cureus.32123 PubMed
33. [33] Salih Demir et al.. Acta Medica (Hradec Kralove). 2021. Restless Leg Syndrome and Sleep Disorders in Patients with Rheumatoid Arthritis and Its Relation with Anemia Parameters. doi:10.14712/18059694.2021.24 PubMed
34. [34] Anisha Garg et al.. Curr Diab Rep. 2021. Diagnostic and Treatment Considerations in Restless Legs Syndrome Complicated by Diabetic Neuropathy. doi:10.1007/s11892-021-01431-2 PubMed
35. [35] Benjamin Elstrott et al.. Eur J Haematol. 2020. The role of iron repletion in adult iron deficiency anemia and other diseases. doi:10.1111/ejh.13345 PubMed
36. [36] Solam Lee et al.. J Am Acad Dermatol. 2019. Comorbidities in alopecia areata: A systematic review and meta-analysis. doi:10.1016/j.jaad.2018.07.013 PubMed
37. [37] Sherifa A Hamed. Expert Rev Clin Pharmacol. 2019. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. doi:10.1080/17512433.2019.1555468 PubMed
38. [38] Régis Lopez et al.. Sleep. 2019. Restless legs syndrome and iron deficiency in adults with attention-deficit/hyperactivity disorder. doi:10.1093/sleep/zsz027 PubMed
39. [39] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
40. [40] Dinesh Gowda et al.. Int J Trichology. 2017. Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. doi:10.4103/ijt.ijt_48_16 PubMed
41. [41] Waishu Jin et al.. J Dermatol. 2017. Changes of serum trace elements level in patients with alopecia areata: A meta-analysis. doi:10.1111/1346-8138.13705 PubMed
42. [42] Niloufar Zadeh Saraji et al.. J Renal Inj Prev. 2017. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. doi:10.15171/jrip.2017.27 PubMed
43. [43] Evelyn J Cheung et al.. J Drugs Dermatol. 2016. Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. PubMed
44. [44] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
45. [45] Kirti Deo et al.. Dermatol Res Pract. 2016. Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. doi:10.1155/2016/6279108 PubMed
46. [46] Roshanak Hasheminasab Zaware et al.. Nephrourol Mon. 2016. Insomnia and Restless Leg Syndrome in Patients Undergoing Chronic Hemodialysis in Rafsanjan Ali Ibn Abitaleb Hospital. doi:10.5812/numonthly.29527 PubMed
47. [47] Ashutosh Singh et al.. Transfus Apher Sci. 2016. Importance of donor history of restless leg syndrome and pica to asses iron deficiency. doi:10.1016/j.transci.2015.09.002 PubMed
48. [48] Caroline Bittencourt et al.. Int J Dermatol. 2016. Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation. doi:10.1111/ijd.13200 PubMed
49. [49] Jana Zímová et al.. Acta Dermatovenerol Croat. 2016. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. PubMed
50. [50] Mehmet Kolukisa et al.. Ideggyogy Sz. 2016. Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia. doi:10.18071/isz.69.0356 PubMed
51. [51] Andrew J Ghio. Biometals. 2016. Asthma as a disruption in iron homeostasis. doi:10.1007/s10534-016-9948-y PubMed
52. [52] Richard P Allen. Sleep Med Clin. 2015. Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology. doi:10.1016/j.jsmc.2015.05.022 PubMed
53. [53] Shashikant Malkud. J Clin Diagn Res. 2015. A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. doi:10.7860/JCDR/2015/14089.6170 PubMed
54. [54] Tahir Mehmood et al.. Sleep Med. 2014. Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease). doi:10.1016/j.sleep.2014.08.012 PubMed
55. [55] France Woimant et al.. Handb Clin Neurol. 2014. Disorders of heavy metals. doi:10.1016/B978-0-7020-4087-0.00057-7 PubMed
56. [56] Behzad Einollahi et al.. Nephrourol Mon. 2014. Restless leg syndrome: a neglected diagnosis. doi:10.5812/numonthly.22009 PubMed
57. [57] Nicolas Perez-Mora et al.. Dermatol Ther. 2014. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. doi:10.1111/dth.12101 PubMed
58. [58] Beatriz Elizabeth Carmona Toro. J Neurosci Nurs. 2014. New treatment options for the management of restless leg syndrome. doi:10.1097/JNN.0000000000000068 PubMed
59. [59] Maria Rogalidou et al.. Ann Gastroenterol. 2014. Telogen effluvium as the first symptom of Crohn's disease in a child. PubMed
60. [60] Hatice Uce Özkol et al.. Turk J Med Sci. 2014. Is TrichoScan a new diagnostic method for diffuse hair loss? doi:10.3906/sag-1212-78 PubMed
61. [61] H Rasheed et al.. Skin Pharmacol Physiol. 2013. Serum ferritin and vitamin d in female hair loss: do they play a role? doi:10.1159/000346698 PubMed
62. [62] J Gordon Millichap et al.. Pediatrics. 2012. The diet factor in attention-deficit/hyperactivity disorder. doi:10.1542/peds.2011-2199 PubMed
63. [63] Stefano de Biase et al.. Expert Opin Drug Metab Toxicol. 2012. ADMET considerations for restless leg syndrome drug treatments. doi:10.1517/17425255.2012.708023 PubMed
64. [64] Dinesh Yadav et al.. Indian J Pediatr. 2011. Iron deficiency: beyond anemia. doi:10.1007/s12098-010-0129-7 PubMed
65. [65] Elise A Olsen et al.. J Am Acad Dermatol. 2010. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. doi:10.1016/j.jaad.2009.12.006 PubMed
66. [66] Shyam Behari Shrivastava. Indian J Dermatol Venereol Leprol. 2009. Diffuse hair loss in an adult female: approach to diagnosis and management. doi:10.4103/0378-6323.45215 PubMed
67. [67] Gisele Zandman-Goddard et al.. Isr Med Assoc J. 2008. Hyperferritinemia in autoimmunity. PubMed
68. [68] Rajiv Agarwal. Am J Nephrol. 2007. Nonhematological benefits of iron. doi:10.1159/000107927 PubMed
69. [69] Leonid Benjamin Trost et al.. J Am Acad Dermatol. 2006. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. doi:10.1016/j.jaad.2005.11.1104 PubMed
70. [70] Maria K Hordinsky. Semin Cutan Med Surg. 2006. Medical treatment of noncicatricial alopecia. doi:10.1016/j.sder.2006.01.007 PubMed
71. [71] Jonathan Kantor et al.. J Invest Dermatol. 2003. Decreased serum ferritin is associated with alopecia in women. doi:10.1046/j.1523-1747.2003.12540.x PubMed
72. [72] Jean Krieger et al.. Sleep Med Rev. 2001. Iron, brain and restless legs syndrome. doi:10.1053/smrv.2001.0156 PubMed
73. [73] D H Rushton. Dermatol Clin. 1993. Management of hair loss in women. PubMed